NCT00775632 2016-06-23Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell TransplantsUniversity Health Network, TorontoPhase 2 Completed78 enrolled
NCT00781781 2015-02-04Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity ConditioningCABYCPhase 2 Terminated34 enrolled
NCT00109993 2010-06-11Campath-1H + FK506 and Methylprednisolone for GVHDCase Comprehensive Cancer CenterPhase 2 Completed34 enrolled
NCT00410657 2010-05-14Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled